Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact
Priya Life Science Clinical trial register
Trackers› Clinical trials› Parkinson Disease
Clinical trial register · Spain

Parkinson Disease Trials in Spain, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Spain and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 5882 matching records held by the registry are in this view. Synced 10 Nov 2026, 03:19 UTC
5882
Studies in scope
all four open statuses
3093
Recruiting now
open to new participants
1126
Lead sponsors
across recruiting studies
Top sites
Madrid 9 Barcelona 7 Seville 6 Valencia 4 Pamplona 3

Parkinson Disease trials in Spain

20 of 5882 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Spain
Start
Not yet open
University of Valencia
Not applicable
50
Valencia
2026-05-30
Recruiting
Universidad Rey Juan Carlos
Not applicable
100
Fuenlabrada
2026-05-10
Not yet open
Universidad Villanueva
Not applicable
22
Madrid
2025-09-07
Not yet open
University of Valencia
Not applicable
74
Valencia
2025-09
Active, closed
Fundacion Clinic per a la Recerca Biomédica
Phase 2
66
Barcelona
2025-02-04
Recruiting
A Phase 2 Study and Open-Label Extension of NEU-411 in Companion Diagnostic-Positive Participants With Early Parkinson's Disease
NCT06680830Parkinson Disease, Parkinson, Idiopathic Parkinson Disease, Early Parkinson Disease (Early PD)
Neuron23 Inc.
Phase 2
150
San Sebastián, Barakaldo, Barcelona, Madrid, Móstoles, Seville
2025-01-17
By invitation
Universidad Politecnica de Madrid
Observational
40
Madrid
2024-12-09
Active, closed
Denali Therapeutics Inc.
Phase 2
50
Barcelona, Donostia / San Sebastian, Madrid, Santander, Seville
2024-10-24
Active, closed
Cerevance
Phase 3
330
Seville, Sant Cugat del Vallès, Barakaldo, San Sebastián, Valencia, Barcelona, Madrid
2024-09-20
Active, closed
Manual Therapy in Parkinson's Disease
NCT06853262Parkinson Disease
University of La Laguna
Not applicable
60
San Cristóbal de La Laguna
2024-04-01
Active, closed
AC Immune SA
Phase 2
150
Barcelona, Donostia / San Sebastian, Madrid, Majadahonda, Pozuelo de Alarcón
2023-07-24
Active, closed
Abbott Medical Devices
Not applicable
100
Badalona, Madrid, Seville
2022-03-24
Recruiting
Fundacion Para La Investigacion Hospital La Fe
Not applicable
34
Valencia
2022-03-14
Recruiting
Michael J. Fox Foundation for Parkinson's Research
Observational
4,500
Barcelona, Donostia / San Sebastian
2020-07-01
Recruiting
Abbott DBS Post-Market Study of Outcomes for Indications Over Time
NCT04071847Movement Disorders, Parkinson Disease, Essential Tremor, Tremor
Abbott Medical Devices
Observational
1,000
Seville, Badalona, Madrid
2019-11-26
Recruiting
Deep Brain Stimulation (DBS) Retrospective Outcomes Study
NCT03664609Parkinson Disease, Essential Tremor, Dystonia
Boston Scientific Corporation
Observational
5,000
Seville
2019-03-12
Active, closed
InSightec
Not applicable
92
Móstoles, Pamplona
2018-02-09
Recruiting
Systematic Assessment of Laryngopharyngeal Function in Patients With Neurodegenerative Diseases
NCT04706234Multiple System Atrophy, Parkinson Disease, Progressive Supranuclear Palsy, Motor Neuron Disease
Kliniken Beelitz GmbH
Observational
350
Barcelona
2017-09-01
Rows per page Showing 1–20 of 20
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Spanish investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 12 November 2026. https://priyalifescience.com/clinical-trials-spain/condition/parkinson-disease

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Spain and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 5,882 studies in total at the last sync on 10 Nov 2026, 03:19 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 20 of those studies listing the condition Parkinson Disease.

How many Parkinson Disease trials are recruiting in Spain?

7 of the 20 studies on this page are recruiting new participants as of the 10 Nov 2026, 03:19 UTC sync. A further 3 have not yet opened recruitment, 9 are active but closed to new participants, and 1 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Parkinson Disease), 20 studies
PhaseStudiesRecruitingShare
Not applicable10250%
Observational5425%
Phase 24120%
Phase 3105%

Most active sponsors

Lead sponsors with the most studies (Parkinson Disease)
Lead sponsorStudiesRecruiting
InSightec30
Abbott Medical Devices21
University of Valencia20
AC Immune SA10
Boston Scientific Corporation11
Cerevance10
Denali Therapeutics Inc.10
Fundacion Clinic per a la Recerca Biomédica10
Fundacion Para La Investigacion Hospital La Fe11
Kliniken Beelitz GmbH11
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.